hemophilia gene therapy

Actionable Insights Powered by AI

BioMarin Undergoes Strategic Restructuring Amid Slow Roctavian Sales and Staff Layoffs

BioMarin, restructuring, Roctavian, staff layoffs, corporate strategy, hemophilia gene therapy